Frontier Pharma: Schizophrenia – Diverse First-in-Class Pipeline Analyzed in a New Business Study
Albany, US, 2018-Jun-22 — /EPR Network/ —Medical institutions and pharmaceutical companies are akin on developing niche products that accelerate schizophrenia therapeutics pertaining to cognitive symptoms. [read full press release…]